Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2025-12-24 @ 9:48 PM
NCT ID:
NCT05601232
Eligibility Criteria:
Inclusion Criteria:
* Written informed consent must be obtained from the subject.
* Histologically documented primary skin angiosarcoma.
* Locally advanced or locally recurrent angiosarcoma, and not eligible for curative surgery, chemoradiotherapy or radiotherapy. (Including cases where the individual refuses treatment.)
* Measurable disease, as defined by RECIST v1.1.
* The longest diameter of the entire target lesion is 15 cm or less.
* ECOG performance status score of Grade 0 to 2
Exclusion Criteria:
* Apparent disseminated tumor lesions.
* Hereditary fructose intolerance.
* Phenylketonuria.
* Any serious concomitant disease that precludes completion of the study treatment.
* The target lesion has received radiation exceeding 75 Gy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
89 Years
Study:
NCT05601232
Study Brief:
Protocol Section:
NCT05601232